Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) Income from Non-Controlling Interests (2022 - 2024)

Jaguar Health (JAGX) has disclosed Income from Non-Controlling Interests for 3 consecutive years, with -$136000.0 as the latest value for Q2 2024.

  • On a quarterly basis, Income from Non-Controlling Interests rose 3.55% to -$136000.0 in Q2 2024 year-over-year; TTM through Jun 2024 was -$543000.0, a 49.54% increase, with the full-year FY2024 number at -$759000.0, down 26.29% from a year prior.
  • Income from Non-Controlling Interests was -$136000.0 for Q2 2024 at Jaguar Health, up from -$142000.0 in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of -$23000.0 in Q2 2022 to a low of -$651000.0 in Q4 2022.
  • A 3-year average of -$182000.0 and a median of -$140000.0 in 2023 define the central range for Income from Non-Controlling Interests.
  • Biggest YoY gain for Income from Non-Controlling Interests was 78.65% in 2023; the steepest drop was 513.04% in 2023.
  • Jaguar Health's Income from Non-Controlling Interests stood at -$651000.0 in 2022, then skyrocketed by 78.65% to -$139000.0 in 2023, then rose by 2.16% to -$136000.0 in 2024.
  • Per Business Quant, the three most recent readings for JAGX's Income from Non-Controlling Interests are -$136000.0 (Q2 2024), -$142000.0 (Q1 2024), and -$139000.0 (Q4 2023).